AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases (Leah Rosenbaum/Forbes)
AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases — Startups that want to leverage artificial intelligence in drug discovery are a dime a dozen in today's biotech landscape.
via Techmeme
AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases (Leah Rosenbaum/Forbes)
![]()
Reviewed by Internet Chicks Blogger
on
September 13, 2020
Rating:
No comments: